Cargando…

Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3

Safety assessment of UV filters for human health by the Scientific Committee on Consumer Safety (SCCS) is based on the estimation of internal dose following external (skin) application of cosmetic products, and comparison with a toxicological reference value after conversion to internal dose. Data f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousselle, Christophe, Meslin, Matthieu, Berman, Tamar, Woutersen, Marjolijn, Bil, Wieneke, Wildeman, Jenna, Chaudhry, Qasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877280/
https://www.ncbi.nlm.nih.gov/pubmed/35202282
http://dx.doi.org/10.3390/toxics10020096
_version_ 1784658383091007488
author Rousselle, Christophe
Meslin, Matthieu
Berman, Tamar
Woutersen, Marjolijn
Bil, Wieneke
Wildeman, Jenna
Chaudhry, Qasim
author_facet Rousselle, Christophe
Meslin, Matthieu
Berman, Tamar
Woutersen, Marjolijn
Bil, Wieneke
Wildeman, Jenna
Chaudhry, Qasim
author_sort Rousselle, Christophe
collection PubMed
description Safety assessment of UV filters for human health by the Scientific Committee on Consumer Safety (SCCS) is based on the estimation of internal dose following external (skin) application of cosmetic products, and comparison with a toxicological reference value after conversion to internal dose. Data from human biomonitoring (HBM) could be very useful in this regard, because it is based on the measurement of real-life internal exposure of the human population to a chemical. UV filters were included in the priority list of compounds to be addressed under the European Human Biomonitoring Initiative (HBM4EU), and risk assessment of benzophenone-3 (BP-3) was carried out based on HBM data. Using BP-3 as an example, this study investigated the benefits and limitations of the use of external versus internal exposure data to explore the usefulness of HBM to support the risk assessment of cosmetic ingredients. The results show that both approaches did indicate a risk to human health under certain levels of exposure. They also highlight the need for more robust exposure data on BP-3 and other cosmetic ingredients, and a standardized framework for incorporating HBM data in the risk assessment of cosmetic products.
format Online
Article
Text
id pubmed-8877280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88772802022-02-26 Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3 Rousselle, Christophe Meslin, Matthieu Berman, Tamar Woutersen, Marjolijn Bil, Wieneke Wildeman, Jenna Chaudhry, Qasim Toxics Article Safety assessment of UV filters for human health by the Scientific Committee on Consumer Safety (SCCS) is based on the estimation of internal dose following external (skin) application of cosmetic products, and comparison with a toxicological reference value after conversion to internal dose. Data from human biomonitoring (HBM) could be very useful in this regard, because it is based on the measurement of real-life internal exposure of the human population to a chemical. UV filters were included in the priority list of compounds to be addressed under the European Human Biomonitoring Initiative (HBM4EU), and risk assessment of benzophenone-3 (BP-3) was carried out based on HBM data. Using BP-3 as an example, this study investigated the benefits and limitations of the use of external versus internal exposure data to explore the usefulness of HBM to support the risk assessment of cosmetic ingredients. The results show that both approaches did indicate a risk to human health under certain levels of exposure. They also highlight the need for more robust exposure data on BP-3 and other cosmetic ingredients, and a standardized framework for incorporating HBM data in the risk assessment of cosmetic products. MDPI 2022-02-19 /pmc/articles/PMC8877280/ /pubmed/35202282 http://dx.doi.org/10.3390/toxics10020096 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rousselle, Christophe
Meslin, Matthieu
Berman, Tamar
Woutersen, Marjolijn
Bil, Wieneke
Wildeman, Jenna
Chaudhry, Qasim
Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
title Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
title_full Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
title_fullStr Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
title_full_unstemmed Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
title_short Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
title_sort using human biomonitoring data to support risk assessment of cosmetic ingredients—a case study of benzophenone-3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877280/
https://www.ncbi.nlm.nih.gov/pubmed/35202282
http://dx.doi.org/10.3390/toxics10020096
work_keys_str_mv AT roussellechristophe usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3
AT meslinmatthieu usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3
AT bermantamar usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3
AT woutersenmarjolijn usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3
AT bilwieneke usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3
AT wildemanjenna usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3
AT chaudhryqasim usinghumanbiomonitoringdatatosupportriskassessmentofcosmeticingredientsacasestudyofbenzophenone3